David J. Harrison

Little France Crescent
Edinburgh, SCT, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 152 publications

LadderMIL: Multiple-instance Learning with Coarse-to-Fine Self-Distillation.

LadderMIL: Multiple-instance Learning with Coarse-to-Fine Self-Distillation.

Journal: IEEE journal of biomedical and health informatics
Published: August 19, 2026

Probing the Human 4-Oxo-l-proline Reductase-Catalyzed Reaction by Deuterium Kinetic and Equilibrium Isotope Effects.

Probing the Human 4-Oxo-l-proline Reductase-Catalyzed Reaction by Deuterium Kinetic and Equilibrium Isotope Effects.

Journal: Biochemistry
Published: June 15, 2026

Multi-site validation of an AI-based biomarker test for determining ER, PR, and HER2 status from H&E-stained breast cancer slides.

Multi-site validation of an AI-based biomarker test for determining ER, PR, and HER2 status from H&E-stained breast cancer slides.

Journal: ESMO real world data and digital oncology
Published: April 22, 2026

Breast Cancer Hormone Receptor Status Determination from H&E-Stained Biopsy Images Using Pixel-Level Classifiers.

Breast Cancer Hormone Receptor Status Determination from H&E-Stained Biopsy Images Using Pixel-Level Classifiers.

Journal: Cancers
Published: April 09, 2026

Multiplexed P21/MCM-2 Detection Predicts Relapse and May Identify Tyrosine Kinase Inhibitor-Resistant Patients in Clear Cell Renal Cell Carcinoma.

Multiplexed P21/MCM-2 Detection Predicts Relapse and May Identify Tyrosine Kinase Inhibitor-Resistant Patients in Clear Cell Renal Cell Carcinoma.

Journal: Cancer research communications
Published: December 19, 2025

Long-Read Spatial Transcriptomics of Patient-Derived Clear Cell Renal Cell Carcinoma Organoids Identifies Heterogeneity and Transcriptional Remodelling Following NUC-7738 Treatment.

Long-Read Spatial Transcriptomics of Patient-Derived Clear Cell Renal Cell Carcinoma Organoids Identifies Heterogeneity and Transcriptional Remodelling Following NUC-7738 Treatment.

Journal: Cancers
Published: December 04, 2025

Improved Nucleoside (2'-Deoxy)Ribosyltransferases Maximize Enzyme Promiscuity while Maintaining Catalytic Efficiency.

Improved Nucleoside (2'-Deoxy)Ribosyltransferases Maximize Enzyme Promiscuity while Maintaining Catalytic Efficiency.

Journal: ACS chemical biology
Published: October 18, 2025

The energy landscape of N-ribosidic bond cleavage catalysed by 2'-deoxynucleoside 5'-phosphate N-hydrolase 1.

The energy landscape of N-ribosidic bond cleavage catalysed by 2'-deoxynucleoside 5'-phosphate N-hydrolase 1.

Journal: The Biochemical journal
Published: August 21, 2025

H&E-based MSI/MMR testing with AI in colorectal cancer: a multi-centred blinded evaluation.

H&E-based MSI/MMR testing with AI in colorectal cancer: a multi-centred blinded evaluation.

Journal: NPJ digital medicine
Published: July 30, 2025

Leveraging knowledge for explainable AI in personalized cancer treatment: challenges and future directions.

Leveraging knowledge for explainable AI in personalized cancer treatment: challenges and future directions.

Journal: Frontiers in digital health
Published: May 28, 2025

Complex cognitive and motivational deficits precede motor dysfunction in the zQ175 (190 CAG repeat) Huntington's disease model.

Complex cognitive and motivational deficits precede motor dysfunction in the zQ175 (190 CAG repeat) Huntington's disease model.

Journal: Experimental neurology
Published: April 11, 2025

Kidney tumoroid characterisation by spatial mass spectrometry with same-section multiplex immunofluorescence uncovers tumour microenvironment lipid signatures associated with aggressive tumour phenotypes.

Kidney tumoroid characterisation by spatial mass spectrometry with same-section multiplex immunofluorescence uncovers tumour microenvironment lipid signatures associated with aggressive tumour phenotypes.

Journal: Npj imaging
Published: February 25, 2025
Showing 1-12 of 152

Last Updated: 09/26/2026